CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

BACKGROUND: Th17 cells are CD4+ cells that produce interleukin 17 (IL-17) and are potent inducers of tissue inflammation and autoimmunity. We studied the levels of this T cell subset in peripheral blood of patients treated with the anti-CTLA4 antibody tremelimumab since its major dose limiting toxic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: von Euw, Erika, Chodon, Thinle, Attar, Narsis, Jalil, Jason, Koya, Richard C, Comin-Anduix, Begonya, Ribas, Antoni
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697137/
https://ncbi.nlm.nih.gov/pubmed/19457253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-7-35
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller